Skip to main content

Find Clinical Trials

Home
Conditions
Ependymoma

Clinical trial condition

Ependymoma

Explore clinical trials studying Ependymoma. Study availability and eligibility vary by location and protocol.

171 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Ependymoma trial results

Recruiting

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

NCT06193759

Conditions: Atypical Teratoid/Rhabdoid Tumor of CNS, Brain Diseases, Brain Neoplasms, +23 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

NCT04732065

Conditions: Astrocytoma, CNS Tumor, Central Nervous System Neoplasms, +19 more
Locations: University of California, San Francisco San Francisco, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

Emory University Atlanta, Georgia, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Recruiting

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

NCT07424092

Conditions: Disease Attributes, Embryonal Tumor of Brain, Ependymoma, +15 more
Locations: Princess Máxima Centrum Utrecht, Netherlands

Cancer Center Clínica Universidad de Navarra Pamplona, Navarre, Spain

View Trial Details

Recruiting

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

NCT03750513

Conditions: Anaplastic Ependymoma, Ependymoma, Glioma, +7 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

NCT04185038

Conditions: Atypical Teratoid/Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +29 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Recruiting

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

NCT05957679

Conditions: Astrocytoma, Central Nervous System Diseases, Central Nervous System Neoplasms, +24 more
Locations: Shengjing Hospital Shenyang, Liaoning, China

View Trial Details

Recruiting

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

NCT05106296

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Augusta University, Georgia Cancer Center Augusta, Georgia, United States

View Trial Details

Recruiting

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT04541082

Conditions: Anaplastic Astrocytoma, Anaplastic Meningioma, Anaplastic Oligodendroglioma, +41 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Recruiting

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

NCT05259605

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +30 more
Locations: Innsbruck Universitaetsklinik Innsbruck, Austria

Universitaetsklinikum Wien - AKH unikliniken Vienna, Austria

Onze Lieve Vrouw Ziekenhuis Aalst, Belgium

Institut Jules Bordet Anderlecht, Belgium

View all 42 locations

View Trial Details